INTERNATIONAL PATENT: IMMUNITYBIO, INC. FILES APPLICATION FOR "COMPOSITIONS AND METHODS RELATED TO POTENT CYTOTOXIC M-CENK CELLS FROM CD3/CD14-DEPLETED APHERESIS PRODUCTS"

GENEVA, Feb. 4 -- IMMUNITYBIO, INC. (3530 John Hopkins CourtSan Diego, California 92121) filed a patent application (PCT/US2025/038711) for "COMPOSITIONS AND METHODS RELATED TO POTENT CYTOTOXIC M-CENK CELLS FROM CD3/CD14-DEPLETED APHERESIS PRODUCTS" on Jul 22, 2025. With publication no. WO/2026/024752, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANOWER-E-KHUDA, Ferdous (c/o ImmunityBio, Inc.3530 John Hopkins CourtSan Diego, California 92121), YEH, Gene (c/o ImmunityBio, Inc.3530 John Hopkins CourtSan Diego, California...